WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker sent a letter to President Biden affirming the industry’s support of the administration’s national COVID-19 strategy and sharing the industry’s perspective on invocation and use of the Defense Production Act (DPA).
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker released the following statement:
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker released the following statement about AdvaMed’s participation on the HHS Vaccine Consultation Panel.
WASHINGTON, D.C. – Today, AdvaMed President and CEO Scott Whitaker commended CMS on the rule the agency released today establishing a new coverage pathway – MCIT – for breakthrough medical technologies:
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today named DeChane Dorsey the new Executive Director of AdvaMed Accel, the division within AdvaMed dedicated to the needs of small and start-up medical technology manufacturers. DeChane was previously AdvaMed’s Vice President of Payment and Health Care Delivery Policy, a role she has held since 2006.
WASHINGTON, D.C. – In a statement today from AdvaMed President and CEO Scott Whitaker, the world’s largest trade association representing medical technology companies and manufacturers praised California Gov. Gavin Newsom for unveiling a budget proposal that calls for expanding Medi-Cal coverage of continuous glucose monitors (CGMs) by $12 million.
WASHINGTON, D.C. – On behalf of AdvaMed, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
Washington, D.C. — The MedTech Conference won several International Association of Exhibitions and Events (IAEE) Art of the Show Competition awards, including Best Email Promotion Campaign, Best Show Promotion Website, and tied for the prestigious Best of Show award, representing the highest overall score in the competition. The Art of the Show Competition recognizes excellence in promotional materials for the exhibitions and events industry.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Ecuador Trade Package announced today.
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry shows that total U.S. shipments of COVID-19 molecular diagnostic tests have topped more than 255 million since the beginning of the pandemic.